The protein Pal (peptidoglycan-associated lipoprotein) is anchored in the outer membrane (OM) of Gram-negative bacteria and interacts with Tol proteins. Tol-Pal proteins form two complexes: the first is composed of three inner membrane Tol proteins (TolA, TolQ and TolR); the second consists of the TolB and Pal proteins linked to the cell's OM. These complexes interact with one another forming a multiprotein membrane-spanning system. It has recently been demonstrated that Pal is essential for bacterial survival and pathogenesis, although its role in virulence has not been clearly defined. This review summarizes the available data concerning the structure and function of Pal and its role in pathogenesis.
Introduction
Cell envelopes of Gram-negative bacteria consist of three layers: a lipid-protein inner (cytoplasmic) membrane (IM), an outer membrane (OM) composed mainly of lipopolysaccharides and proteins, and a thin rigid layer of peptidoglycan (polymeric chains of N-acetylmuramic acid and N-acetylglucosamine linked by short peptides) located in the periplasmic space. Peptidoglycan has the ability to interact with many proteins of the cell envelope, conditioning their stability. One of these is the peptidoglycan-associated lipoprotein (Pal), which constitutes part of the Tol-Pal protein system. In the majority of Gram-negative bacteria, the Tol-Pal complex is composed of five core proteins: TolQ, TolR, TolA, TolB and Pal. The Tol-Pal system forms a membrane-spanning multiprotein complex that exhibits structural and functional similarities to the MotA-B proteins (flagellar motor) and the TonB system (TonB, ExbB and ExbD) (Eick-Helmerich & Braun, 1989; Cascales et al., 2001) . The TonB and Tol-Pal complexes participate in the penetration of phage particles into the cell (Riechmann & Holliger, 1997; Heilpern & Waldor, 2000) and in the translocation of colicins through the cell envelope (Webster, 1991; Bouveret et al., 1997 Bouveret et al., , 1998 .
The transcriptional organization of Escherichia coli genes encoding the Tol-Pal system has been characterized in detail. The genes comprise two adjacent operons that are positioned on the chromosome in the following order: (ybgC-tolQ-tolR-tolA)(tolB-pal-ybgF). Their transcription mainly occurs from two promoters located upstream of the 5 0 ends of genes ybgC and tolB, although the presence of a long ybgC-ybgF transcript has been observed Muller & Webster, 1997) . A similar organization is exhibited by the tol-pal genes in Pseudomonas putida (named tol-oprL in this microorganism) (Llamas et al., 2003a) , Actinobacillus actinomycetemcomitans (now referred to as Aggregatibacter actinomycetemcomitans) (Paul-Satyaseela et al., 2006) and Erwinia chrysanthemi (Dubuisson et al., 2005) . However, the tol-pal gene cluster is not universal. It has been identified in most sequenced genomes of Gram-negative bacteria except those of the spirochetes (Treponema pallidum and Borellia burgdorferi), Rickettsia prowazeki and Neisseria meningitidis. The gene cluster has not been found in archaea and in Gram-positive eubacteria (Sturgis, 2001) . The lowest level of sequence conservation relative to other cluster members is observed in the gene encoding TolA (Sturgis, 2001) .
The Pal family of proteins is widespread in Gram-negative bacteria with sequence homologs identified in 4 100 species (Parsons et al., 2006) .
Although ubiquitous in Gram-negative organisms, TolB and Pal are poorly conserved proteins; for example, among the sequences of 20 Gammaproteobacteria homologs, only c. 13% and c. 19% of TolB and Pal residues, respectively, are identical (Bonsor et al., 2007) .
Structure of Pal and the Tol--Pal complex
Pal of E. coli is synthesized as a precursor of 173 amino acids. This contains a signal sequence typical of lipoprotein precursors, including a characteristic LVAC motif cleaved by signal peptidase II during translocation through the cytoplasmic membrane. The first amino acid of the mature protein is a cysteine residue that is modified with lipids. The N-terminal end of the lipoprotein is hydrophobic and is responsible for anchoring the protein in the membrane. The second amino acid of the mature protein (12), which determines the localization of Pal in the OM, is serine. Proper translocation of Pal through the cytoplasmic membrane and its correct localization are dependent on the Lol protein system (Liang et al., 2005) . The N-terminal region of Pal is likely to form a flexible tail, which binds the protein to the inner leaflet of the OM via lipid moieties linked to the cysteine at the 11 position Cascales & Lloubes, 2004) . The C-terminal region of Pal interacts with the cell wall peptidoglycan (Lazzaroni & Portalier, 1992) . The structure of the complex between the periplasmic domain of Pal from Haemophilus influenzae (also known as P6) and the peptidoglycan precursor (PG-P) was solved by Parsons et al. (2006) using nuclear magnetic resonance (NMR) spectroscopy. They demonstrated that the majority of contacts are between conserved surface residues of Pal and the peptide region of PG-P. A specific region of Pal provides a pocket for the m-Dap residue of PG-P: a component of the cell wall present in the peptidoglycan layer of all Gram-negative bacteria. Thus, Pal forms a cross-bridge between the OM and peptidoglycan Cascales & Lloubes, 2004; Parsons et al., 2006) . TolB, which is located in the periplasm, contains an Nterminal region comprised of a five-stranded mixed b-sheet structure that sandwiches two major a-helices, and a Cterminal region with a six-bladed b-propeller domain. This domain competes with peptidoglycan to bind Pal (Abergel et al., 1999; Carr et al., 2000) . TolB is considered to be an adapter protein that coordinates the association of OM/Pal with the peptidoglycan and the IM.
The other components of the Tol-Pal complex are three IM proteins TolQ, TolR and TolA, which associate via their transmembrane helices.
TolQ is a protein of 230 amino acids that contains three transmembrane domains and two large cytoplasmic loops (Kampfenkel & Braun, 1993; Parsons et al., 2008) .
The 421-amino acid TolA protein is composed of three structural domains: the transmembrane TolAI domain (amino acids 1-47), and . TolAI, which anchors the protein in the cytoplasmic membrane, is separated from the globular periplasmic domain TolAIII by a periplasmic central domain (TolAII) with a high degree of a-helical structure (Derouiche et al., 1999) . The three domains are separated by segments rich in glycine residues, which provide a certain level of flexibility (Levengood et al., 1991) . The C-terminal domain of TolA is responsible for interaction with the Nterminal domain of colicin A (AT1) and phage g3p (Lubkowski et al., 1999; Bouveret et al., 2002; Bonsor et al., 2007) . The three-dimensional structure of free TolAIII was solved by Deprez et al. (2005) using NMR spectroscopy. They compared it with the available crystal structure of the g3pN1-TolAIII complex and found that the global fold of TolAIII is essentially the same in both the free form and the complex. Some changes in the secondary structure of TolAIII in the complex with g3pN1 were observed, especially in the a1 helix and b3 strand, which are involved in the interaction between the proteins (Deprez et al., 2005) .
It has been postulated that TolR (142-amino acid protein), besides the membrane-anchoring segment (TolRI), possesses a short central domain (TolRII) and a periplasmic C-terminal domain (TolRIII) that interacts with the cytoplasmic membrane Journet et al., 1999) . However, Parsons et al. (2008) solved the NMR structure of the homodimeric periplasmic domain of TolR from H. influenzae and proposed a new structural model. According to this model, TolR has only two domains (transmembrane and periplasmic) and a C-terminal tail. In contrast to its homolog ExbD, the TolR periplasmic domain forms a dimer and its C-terminal tail is oriented toward the IM and probably interacts with TolQ (Parsons et al., 2008) .
TolQ and TolR are homologous to ExbB and ExbD of the TonB system, respectively, while TolA is a homolog of TonB Zhai et al., 2003) . Amino acid sequence analyses of the transmembrane domains of the TolQ and TolR proteins revealed their structural and functional similarity not only to the ExbB and ExbD proteins but also to MotA and MotB of the flagellar apparatus. Similarities between the C-terminal 'hairpin' structures of TolQ, ExbB and MotA as well as between the N-terminal domains of the TolR, ExbD and MotB transmembrane proteins were identified. A common feature of these three protein systems is their ability to exploit the transmembrane electrochemical gradient as a source of energy .
The Tol-Pal proteins form two complexes (Fig. 1) . The first is a complex of TolQ, TolR and TolA with a 4-6 : 2 : 1 stoichiometry, anchored in the cytoplasmic membrane Zhang et al., 2008) . TolAI interacts with the first TolQ transmembrane domain and with the TolRI transmembrane domain Germon et al., 1998) . The first and third transmembrane domains of TolQ probably also interact with each other . The TolQIII domain interacts with the TolR (TolRI) transmembrane region and with the TolR dimer .
The second complex is composed of TolB and Pal linked to the OM. Pal is anchored in the OM and interacts with the C-terminal domain of the periplasmic TolB, which possesses a b-propeller structure (Bouveret et al., 1995; Ray et al., 2000) . In addition, Pal interacts with TolA and other cell envelope proteins such as OmpA and Lpp. All of these interactions are independent of each other (Cascales & Lloubes, 2004) .
The two Tol-Pal complexes interact with each other via the C-terminal domain of TolA, which is able to bind Pal as well as TolB (Carr et al., 2000; Cascales et al., 2000 Cascales et al., , 2002 Lloubes et al., 2001) . Dubuisson et al. (2002) obtained suppressors of tolA mutations in the tolB gene and confirmed the interaction between TolAIII and the N-terminal domain of TolB. Experiments using the yeast two-hybrid system and cross-linking assays with purified proteins allowed Walburger et al. (2002) to identify the domains of TolA responsible for the interactions with TolB and YbgF.
In vitro analysis of the interactions between the components of these complexes as well as the resolution of the three-dimensional structure of TolB and of the complex formed by the Pal periplasmic domain and the PG-P permitted the precise localization of regions of Pal that are responsible for forming protein complexes (Abergel et al., 1999; Cascales & Lloubes, 2004; Parsons et al., 2006) . By identifying suppressor mutants, Ray et al. (2000) characterized the regions responsible for the interaction between TolB and Pal. The region between amino acid residues 94-121 of Pal is responsible for its interactions with peptidoglycan and TolB, but Pal cannot bind both molecules at the same time (Lazzaroni & Portalier, 1992; Clavel et al., 1998; Bouveret et al., 1999 ).
An elegant study by Bonsor et al. (2007) analyzing the mechanism by which nuclease colicins destabilize the TolPal complex to facilitate their entry into the cell revealed many details of Pal-TolB interaction. They found that there is a substantial overlap between the colicin E9 and Pal binding sites on TolB. The natively disordered region of colicin E9, which is part of its translocation domain, interacts strongly with TolB, resulting in destabilization of the Tol-Pal complex. TolB binding with Pal occurs through an induced-fit mechanism in which both proteins undergo conformational changes (Bonsor et al., 2007) . In addition, the interactions of TolB with other proteins (OmpA and Lpp) are dependent on its interaction with Pal . The interaction of Pal with the OM protein OmpA occurs via a region between amino acid residues 44 and 61, containing a conserved VYF motif. The region of Pal that is responsible for binding to the TolA C-terminal domain (TolB interacts with the same TolA domain) was also identified. It is constituted by 30 C-terminal amino acid residues of Pal, which contain a conserved SYG(K/E) motif termed the TolA box, plus the KNRR motif. Deletion of the SYG(K/E) motif results in loss of the interaction between Pal and TolA, while the KNRR motif has no influence on this process (Cascales & Lloubes, 2004) . Cascales et al. (2000) demonstrated that the TolA-Pal interaction is dependent on the proton motive force (PMF). Interactions between proteins of the Tol-Pal system as well as those with other proteins (OmpA and Lpp), especially TolA-Pal and TolQ-TolR, result in the formation of transenvelope bridges linking the IMs and OMs, and the peptidoglycan layer (Cascales et al., 2000; Walburger et al., 2002) .
Physiological function of the Tol--Pal system in the cells of Gram-negative bacteria
Inactivation of ybgC and ybgF genes within the tol-pal gene cluster of E. coli does not cause noticeable phenotypic changes in the cell. YbgC is a cytoplasmic protein with thioesterase activity (Zhuang et al., 2002; Gully & Bouveret, 2006) , while YbgF is a protein of unknown function located in the periplasm. Mutations in the remaining tol-pal genes evoke various physiological changes such as hypersensitivity to detergents, bile salts and several antibiotics. Other effects include the release of periplasmic proteins from the cell, impaired motility, aberrant cell division and the induction of colanic acid production (Webster, 1991; Clavel et al., 1996; Lazzaroni et al., 1999; Llamas et al., 2000) . Moreover, tolA, tolQ, tolR and pal mutants of E. coli are characterized by their ability to produce large amounts of outer membrane vesicles (OMVs) (Bernadac et al., 1998; Balsalobre et al., 2006) . The aforementioned phenotypic changes produced by mutations in the tol-pal genes suggest that the encoded proteins are involved in maintaining the proper structure and function of the cell envelope.
The findings of other studies also suggest the involvement of the Tol-Pal system in the biogenesis and/or transport of lipopolysaccharide components (Gaspar et al., 2000; Vines et al., 2005) . The TolA and Pal proteins modulate the structure of the surface O-antigen by playing a role in the translocation of its subunits through the OM. Damage to bacterial cell envelopes caused by an abnormal O-antigen structure results in the activation of regulatory cascades (extracytoplasmic stress response pathways). Increased expression of the degP gene, encoding a chaperone protein (protease) has been observed in response to the extracytoplasmic stress caused by inactivation of the tolA and pal genes (Gaspar et al., 2000; Vines et al., 2005) .
Gerding et al. release of vesicles from the OM. Interestingly, 90% of these vesicles also localize at the site of cell division and at the poles of the dividing cell. These authors proposed a hypothetical model for the role of the Tol-Pal complex in the invagination of the OM and in connecting the OM with the IM and peptidoglycan layer during septum formation (Gerding et al., 2007) . As mutations in the Tol-Pal proteins are not always lethal, it is likely that their role may be partially substituted by other OM peptidoglycan-associated proteins, for example Lpp or OmpA. Tol-Pal proteins have also been shown to play a role in the uptake/transport of compounds through the cytoplasmic membrane. Pseudomonas putida tol-oprL gene mutants do not grow or grow very weakly on media containing certain compounds as the sole carbon source (e.g. arginine, fructose, glycerol and saccharose). This is due to perturbations in compound transport and not the abnormal structure/ activity of the OM porins. Similar results were obtained for E. coli and Pseudomonas aeruginosa tol-pal gene mutants (Llamas et al., 2003b) . Llamas et al. (2003b) also reported that the PMF in P. putida tolA, tolB and oprL mutants is similar to that produced by the wild-type strain, but is lower in tolQ and tolR mutants.
Role of Pal in the process of pathogenesis Role of lipoproteins in pathogenesis
The results of recent studies indicate a significant role for lipoproteins in the pathogenesis of bacterial infections caused by species such as Yersinia pestis (Sha et al., 2008) , P. aeruginosa (Rau et al., 2006) , Salmonella enterica sv. Typhimurium (Sha et al., 2004) , N. meningitidis (Delgado et al., 2007) , Borrelia burgdorferi (Porcella & Schwan, 2001 ) and Mycobacterium tuberculosis (Neufert et al., 2001) . Bacterial lipoproteins belong to the so-called pathogen-associated molecular patterns modulating the host immune response.
They are recognized by Toll-like receptors (TLRs) located mainly on the surface of antigen-presenting cells, for example macrophages and dendritic cells. This leads to the activation of a signal transduction cascade (Fig. 2) , which results in proinflammatory cytokine gene transcription. Lipoproteins are recognized by class TLR2 receptors (Aliprantis et al., 1999) in a manner dependent on TLR6 or TLR1, which participate in the induction of immune responses to diacylated (Takeuchi et al., 2001) or triacylated molecules (Takeuchi et al., 2002) , respectively. For certain lipoproteins, the signaling cascades are stimulated independently of TLR1 and TLR6 (Buwitt-Beckmann et al., 2006) . Some Gram-negative microorganisms have the ability to secrete lipoproteins to the extracellular environment. Among these is Pal, which is released into the bloodstream during infection, and this process contributes to the development of septic shock (Hellman et al., 2002; Liang et al., 2005) .
Role of Pal in pathogenesis

Escherichia coli
During experimentally induced sepsis in mice caused by E. coli infection, significant amounts of Pal are released into the bloodstream. The addition of purified Pal (in amounts of 10 mg) to the C3H/HeJ mouse cell line resulted in the induction of immune responses in macrophages and spleen lymphocytes similar to those observed following lipopolysaccharide application (increased production of tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6) and nitric oxide), and induced early sepsis symptoms. The administration of Pal to D-galactosamine-sensitized mice at doses of 1, 10 and 100 mg was found to cause death with a lethal dose 50% of 3 mg per mouse (Hellman et al., 2002; Liang et al., 2005) .
The infection of C3H/HeN mice with E. coli strains exhibiting decreased expression of the pal gene or producing a truncated form of the protein led to the development of a mild form of sepsis characterized by increased survival of infected animals and lower levels of IL-6 in the blood (Hellman et al., 2002) . Bacteria with a mutated pal gene might be less efficient in inducing sepsis for several reasons. Possibly, disorders in the functioning of the bacterial cell envelope caused by structural alteration or deficiency of Pal aid the host immune system to overcome the infection. The effect of passive immunization with mono-and polyclonal anti-Pal antibodies has been tested in three different mouse models of sepsis (cecal ligation and puncture, an infected burn model, and an infected fibrin clot model mimicking peritonitis). However, these trials indicated that this type of strategy does not have any protective/therapeutic effect (Valentine et al., 2006) .
Aggregatibacter actinomycetemcomitans
Antibodies interacting strongly with Pal are present in the serum of patients infected with A. actinomycetemcomitans (Norskov-Lauritsen & Kilian, 2006) and suffering from paradontosis. These antibodies cross-react with putative Pal proteins from other microorganisms residing in the oropharyngea (Aggregatibacter aphrophilus, Aggregatibacter paraphrophilus, H. influenzae). A humoral anti-Pal immune Fig. 2 . Signaling cascade in antigen-presenting cells induced by stimulation of TLR2 receptors. Activated TLR2 associates with myeloid differentiation primary-response protein 88 (MyD88) and then recruits of interleukin-1 receptor (IL-1R)-associated kinase 4 (IRAK4) and IRAK1. TNF-receptor-associated factor 6 (TRAF6) binds IRAK1 and then dissociates to form a complex with transforming growth factor-b-activated kinase 1 (TAK1), TAK1-binding protein 1 (TAB1) and TAB2. This complex is required for the ubiquitylation of TRAF6 and for the activation of the kinase activity of TAK1, which then leads to the phosphorylation of components of the IKK complex [the inhibitor of NF-kB (IkB)-kinase complex] and gives rise to downstream activation of NF-kB. Ubc13, ubiquitin-conjugating enzyme 13; Uev1A, ubiquitin-conjugating enzyme E2 variant 1; NF-kB, nuclear factor-kB.
response in patients with paradontosis may be one of the factors that induces the illness symptoms (Ihalin et al., 2006; Paul-Satyaseela et al., 2006) . Aggregatibacter actinomycetemcomitans biofilms and planktonic cells release free soluble material independently of the cell vesicles (Oscarsson et al., 2008) . Along with a GroEL-like protein, Pal was found to be one of the major protein antigens released in this way. This process is likely to have biological significance because free proteins can readily cross biological barriers that are otherwise impermeable to whole bacterial cells or even membrane vesicles. Further studies are required to elucidate the mechanism of the release of Pal from bacterial cell envelopes . Oscarsson et al. (2008) reported that free-soluble material released by wild-type and pal-mutant planktonic A. actinomycetemcomitans cells induce similar cytokine responses in whole blood. However, in a previous study, these authors found that purified Pal stimulates proinflammatory cytokines in whole blood . This discrepancy was attributed to the enhanced release of lipopolysaccharides by the pal-deficient mutant strain (Oscarsson et al., 2008) .
Haemophilus ducreyi
Haemophilus ducreyi is the etiological agent of chancroid, an infectious sexually transmitted genital ulcer disease Bong et al., 2002) . Studies carried out on healthy individuals showed that in comparison with the wild-type strain, an H. ducreyi pal mutant caused less profound skin changes that rarely transformed into ulcerating forms and fewer bacteria were isolated from biopsy samples taken from the forming wound. This finding could be due to the decreased survival of pal mutants or a reduced ability to induce an immune response and the lower numbers of neutrophils, lymphocytes, macrophages or dendritic cells recruited to the site of infection (Fortney et al., 2000) .
Erwinia chrysanthemi
It has been demonstrated that the Tol-Pal complex participates in the virulence of E. chrysanthemi: a pathogen causing soft rot in many plant species including vegetables and ornamentals (Dubuisson et al., 2005) . Bacteria of this species colonize the parenchymatous tissues and break down the plant cell wall material using pectinolytic enzymes, while oligosaccharides, the products of pectin degradation, are utilized as a carbon source. Dubuisson et al. (2005) obtained E. chrysanthemi ybgC, tolQ, tolA, tolB, pal and ybgF gene mutants, characterized by increased sensitivity to bile salts. Bacteria with mutated tolQ, tolA, tolB and pal genes survived only in an environment with increased levels of sugars and osmoprotectants. Changes in cell morphology and abnormal cell division were observed, with the most severe defects seen in pal and tolB mutant cells. The virulence of the mutant strains was examined using potato tuber and chicory leaf models. In vivo all of the obtained mutants damaged plant tissues to a lower extent than the wild-type strain. They also exhibited reduced motility, most probably due to abnormalities in flagellum synthesis. Moreover, apart from the ybgF mutant (which showed increased pectinolytic enzyme activity), the investigated mutants showed decreased pectin-degrading activity: the main virulence factor of E. chrysanthemi (Dubuisson et al., 2005) .
Vibrio cholerae
The mechanism by which Tol-Pal proteins participate in the process of V. cholerae infection (pathogen colonizing the small intestine) has been characterized recently. Cholera exotoxin is the main V. cholerae virulence factor that stimulates the secretory response in epithelial cells leading to diarrhea. The toxin is encoded by the ctxAB operon found in the genome of phage CTXF. The acquisition of phage genes in the course of evolution was an essential step in the development of V. cholerae pathogenicity. Mutants in the tolQRA genes created by Heilpern & Waldor (2000) were defective in the transport of phage CTXF DNA through the periplasm. During phage injection into the bacterial cell, the periplasmic domain of the TolA protein binds the minor coat protein pIII and serves as a coreceptor for phage entry (Riechmann & Holliger, 1997) . Mutation of any of the V. cholerae tolQRA genes was found to decrease the infection ability of the CTXF phage, but did not confer full resistance (Heilpern & Waldor, 2000) . Mutation of the tolB gene had no influence on phage injection into the V. cholerae cells.
Application of Pal in immunoprophylaxis
All Omp18 (Pal) proteins studied so far are highly immunogenic, which makes them attractive antigens for the production of subunit vaccines.
Haemophilus influenzae
Atypical H. influenzae [nontypeable H. influenzae (NTHi)] strains have been investigated as candidates for the development of subunit vaccines based on Pal. NTHis are commonly occurring pathogens of the respiratory tract in both children and adults. Otitis media, one of the most serious childhood illnesses caused by NTHi is currently treated with antibiotic therapy (Murphy et al., 2006) . Considerable research effort has been put into developing a vaccine against NTHi. So far, the most intensively studied vaccine candidate is lipoprotein P6 (16 kDa) from the Pal family. P6 is highly conserved among all strains of this species. Murphy et al. (2006) showed that a P6 gene mutant exhibits abnormal cell morphology and decreased survival. The P6 protein was found to activate the transcription factor nuclear factor-kB in eukaryotic HM3 cells by stimulating TLR2 receptors, leading (among other responses) to increased muc5ac gene transcription, followed by increased mucin production. The muc5ac gene plays a significant role in infectious diseases of the respiratory tract (Chen et al., 2004) . Stimulation of TLR receptors of human macrophages by P6 increases the production of proinflammatory cytokines, especially IL-8, TNF-a and IL-10 (Berenson et al., 2005) . In addition, treatment with protein P6 activates T CD4
1 lymphocyte proliferation and the expression of genes encoding certain cytokines (Kodama et al., 2006) .
Intravenous and mucosal (intranasal) immunization of experimental animals (mouse, rat and chinchilla) with the P6 protein induces a strong specific immune response (e.g. production of specific mucosal type sIgA antibodies) and protects against infection (Badr et al., 1999; Kodama et al., 2006) . The immunogenicity of Pal depends on a 15-amino acid-long peptide (residues 41-55 of the P6 protein sequence). The immunization of mice with this synthetic peptide produced an immune response of the same magnitude as administration of the complete protein and hastened the amelioration of the infection. Modifications of the amino acid sequence showed that effective protection of the immunized animal was afforded only when the peptide induced both lymphocyte B and T responses. This confirmed the importance of both humoral and cellular immune responses in the defensive reaction of the organism against H. influenzae ( McMahon et al., 2005) .
In light of the high number of otitis media cases among children below the age of 2, the possibility of transmitting maternal anti-Pal antibodies to offspring was examined in experimental animals. Yamauchi et al. (2006) showed that female mice transmit specific IgG antibodies against the P6 protein to their offspring. These antibodies were detected in the serum of young directly after birth and in the mother's milk, and persisted for longer in offspring that were breastfed by immunized mothers (Yamauchi et al., 2006) .
Campylobacter jejuni
The cjaD gene of C. jejuni cj0113 (C. jejuni NCTC 1168) was identified by immunological screening of a C. jejuni genomic DNA library using anti-Campylobacter rabbit serum. This gene encodes an 18-kDa protein conserved among many Campylobacter serotypes, which potentially belongs to the Pal family (in silico analysis). This protein contains a signal sequence characteristic of lipoprotein precursors reacting not only with anti-Campylobacter rabbit serum but also with the serum of patients infected with different C. jejuni serotypes (Burnens et al., 1995; Konkel et al., 1996; Pawelec et al., 2000; Wyszynska et al., 2002) . The analysis of proteins from different cellular fractions using rabbit serum raised against rCjaD (fusion protein CjaDx6His expressed in E. coli) demonstrated that CjaD is located in the OM. Proteomic experiments have also shown that Campylobacter Pal (Omp18) is a cell membrane-associated protein and is immunogenic during human infection (Cordwell et al., 2008) . The cjaD gene was cloned in an avirulent S. enterica sv. Typhimurium strain using plasmids from the Asd series that are used to express foreign antigens for vaccine studies. Oral immunization of chickens with the avirulent cjaDcarrying Salmonella strain induced specific class IgG and IgA immune responses in the blood serum and mucus, respectively (E.K. Jagusztyn-Krynicka et al., unpublished data). Until now, attempts to obtain a C. jejuni cjaD mutant have been unsuccessful, which indicates that Pal is essential for cell survival. This feature makes it an attractive potential candidate for vaccine construction.
Legionella pneumophila
Legionella pneumophila is the causative agent of serious respiratory tract diseases, often having the character of local epidemics. This infection is especially dangerous in immunocompromised individuals, for example the elderly or cancer therapy patients. The application of lipoprotein Pal in both the diagnosis and the immunoprophylaxis of legionellosis has been studied. Kim et al. (2003) showed that anti-Pal antibodies effectively detect the presence of Legionella spp. in urine samples of guinea pigs, giving almost no false positive results. Legionella pneumophila is an intracellular pathogen able to multiply in macrophages. As a result, the humoral response developed by patients vaccinated against Legionella sp. was found to be inefficient in combating this pathogen. Yoon et al. (2002) developed a DNA vaccine based on the pal gene and compared its efficiency with immunization with purified recombinant Pal. They observed that intravenously administered Pal is a strong inducer of the humoral response due to the activation of Th2 lymphocytes, but it does not evoke an efficient cellular response. In contrast, intramuscular administration of a plasmid expressing the pal gene from a eukaryotic promoter was found to induce a mainly Th1-type response as well as a strong cytotoxic response, indicating the potential application of Pal-encoding DNA as a vaccine against legionellosis (Yoon et al., 2002) .
Application of OMVs in medicine
Many types of Gram-negative bacteria constitutively secrete OMVs into the extracellular milieu (Kadurugamuwa & Beveridge, 1995 . Compared with wild-type cells, tol-pal gene mutants generally produce increased amounts of OMVs (Bernadac et al., 1998; Kuehn & Kesty, 2005; Lee et al., 2007) . Although the role of the Tol-Pal complex in OMV formation remains to be elucidated, the creation of cells that overproduce OMVs owing to a defect in the Tol-Pal system may be of great value in combating infectious diseases. Such systems may be used as vectors delivering antibiotics to eukaryotic cells or for vaccine development (Henry et al., 2004; Ferrari et al., 2006) .
Neisseria meningitidis, a Gram-negative bacterium categorized into five serogroups, is a major cause of meningitis and sepsis. Effective conjugated capsular polysaccharidebased vaccines have been developed to protect against infection by four serogroups: A, C, W-135 and Y. However, there is no effective vaccine against B strains (MenB), which are very common in some parts of the world. Great effort has recently been put into the development of an anti-MenB vaccine based on OMVs containing OM proteins. Detergent-extracted OMVs (DOMVs) have been tested in phase III clinical trials with promising results (O'Hallahan et al., 2004) . Two important prerequisites for the success of this strategy are a means to control the composition of OMVs and a reproducible method for their production (Vipond et al., 2006) . Ferrari et al. (2006) performed a proteomic comparison of detergent-derived MenB OMVs (DOMVs) with m-OMVs spontaneously released by a MenB strain carrying a deletion of lytic transglycosylase (Dgna33), an enzyme homologous to E. coli MltA. Their analysis showed that m-OMVs contain mainly OM proteins whereas about 70% of DOMV proteins are cytoplasmic or from the IM (Ferrari et al., 2006) .
Conclusions
Studies on Pal and the Tol-Pal system of E. coli have been conducted for over 30 years. They have resulted in a significant understanding of the structure and interactions of these proteins and their involvement in maintaining the integrity of the cell envelope. Besides its structural functions, Pal also appears to play an important role in the pathogenesis of certain Gram-negative bacteria. Despite numerous studies on the potential use of Pal and its synthetic derivatives as vaccines against various pathogens, none of these vaccine prototypes have so far entered the phase of clinical trials. Although Pal is found in many Gram-negative bacteria, immunization against diverse pathogens is likely to require the application of different forms of administration (DNA vaccines vs. subunit protein vaccines) and the use of different adjuvants or carrier strains. Depending on the immunization strategy, the same protein may induce an immune response dependent on Th1 and/or Th2 lymphocytes. Studies aimed at using OMVs as carriers of prophylactic agents have also provided interesting data. Developments in these fields of research are likely to be dependent on further studies on the functional mechanisms of Pal-Tol complexes. Detailed knowledge about the structure of Pal-Tol complexes might also facilitate the design of new antibacterial drugs.
